Publications

Journal Article
Research Support, Non-U.S. Gov't
Ppublish 101 citations
Electronic publication date
March 19, 2014

View on Pubmed.gov 23723074 | View on doi.org 10.1158/1541-77...

Tumor suppressor functions of miR-133a in colorectal cancer.

Search for publications in this journal Mol Cancer Res - 11(9):1051-60

  • Yujuan Dong

    Search for this expert
    1
  • Junhong Zhao

    Search for this expert
  • Chung-Wah Wu
  • Lijing Zhang
  • Xiaodong Liu

    Search for this expert
  • Wei Kang

    Search for this expert
  • Wing-Wah Leung

    Search for this expert
  • Ning Zhang

    Search for this expert
  • Francis K L Chan

    Search for this expert
  • Joseph J Y Sung
  • Simon S M Ng

    Search for this expert
  • Jun Yu

    Search for this expert

Abstract

UNLABELLED

Dysregulated microRNA (miRNA) expression was profiled through a miRNA array comparison between human colorectal cancer tumors and their adjacent normal tissues. Specifically, using laser capture micro-dissection, miR-133a was shown to be significantly downregulated in primary colorectal cancer specimens compared with matched adjacent normal tissue. Ectopic expression of miR-133a significantly suppressed colorectal cancer cell growth in vitro and in vivo. Cell-cycle analysis revealed that miR-133a induced a G0/G1-phase arrest, concomitant with the upregulation of the key G1-phase regulator p21(Cip1). We further revealed that miR-133a markedly increased p53 protein and induced p21(Cip1) transcription. Studies in silico revealed that the 3'UTR of the ring finger and FYVE-like domain containing E3-ubiquitin protein ligase (RFFL), which regulates p53 protein, contains an evolutionarily conserved miR-133a binding site. miR-133a repressed RFFL-3'UTR reporter activity and reduced RFFL protein levels, indicating that miR-133a directly bound to RFFL mRNA and inhibited RFFL translation. Moreover, miR-133a sensitized colon cancer cells to doxorubicin and oxaliplatin by enhancing apoptosis and inhibiting cell proliferation. These data add weight to the significance of miR-133a in the development of CRC.

IMPLICATIONS

miR-133a serves as a potential tumor suppressor upstream of p53 in colorectal cancer and may sensitize cells to therapeutics.

References

No references provided.

Cited by 101 citations (total)

Journal Article Retracted Publication

MicroRNA-133a suppresses colorectal cancer cell invasion by targeting Fascin1.

Electronic publication date January 27, 2015

Search for publications in this journal Oncol Lett

Keyan Zheng [...] Qun Qian et al.

MicroRNAs (miRs) are a type of small non-coding RNA molecule that are involved in gene silencing and the regulation of...

Journal Article

Single nucleotide polymorphisms in microRNA binding sites: implications in colorectal cancer.

Electronic publication date October 20, 2015

Search for publications in this journal ScientificWorldJournal

Panchalee Bhaumik [...] Rituraj Purohit et al.

Cancer is a complex genetic disorder, characterised by uncontrolled cell proliferation and caused by altered expression of oncogenes and tumour...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances

Copyright

©2013 AACR.